Capital Analysts, LLC

Position in MRNA — Moderna, Inc.

CIK 1624758 FORT WASHINGTON, PA

Position in MRNA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$466,292

+$196,076 QoQ

Shares Held

9,179

+0.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Capital Analysts, LLC holds $1,026,985 across 15 Biotechnology names. MRNA ranks #1 (45.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc. This page	9,179	$466,292
2	REGN	Regeneron Pharmaceuticals, Inc.	520	$401,772
3	VRTX	Vertex Pharmaceuticals Inc / Ma	119	$53,137
4	FTRE	Fortrea Holdings Inc.	2,788	$26,262
5	BMRN	Biomarin Pharmaceutical Inc	446	$25,194
6	OMER	Omeros Corp	1,000	$10,560
7	SPRY	ARS Pharmaceuticals, Inc.	1,300	$10,439
8	VRCA	Verrica Pharmaceuticals Inc.	1,500	$7,935

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$466,292	9,179	+0.2%	Shares	Defined	2026-05-14
2025-12-31	$270,216	9,163	-0.2%	Shares	Defined	2026-02-11
2025-09-30	$237,067	9,178	+4512.1%	Shares	Defined	2025-11-14
2025-06-30	$5,490	199	0.0%	Shares	Defined	2025-08-13
2025-03-31	$5,641	199	0.0%	Shares	Defined	2025-05-14
2024-12-31	$8,274	199	+11.8%	Shares	Defined	2025-02-14
2024-09-30	$11,895	178	0.0%	Shares	Defined	2024-11-13
2024-06-30	$21,137	178	+584.6%	Shares	Defined	2024-08-14
2024-03-31	$2,770	26	0.0%	Shares	Defined	2024-05-14
2023-12-31	$2,585	26	0.0%	Shares	Defined	2024-01-30
2023-09-30	$2,685	26	+136.4%	Shares	Defined	2023-11-13
2023-06-30	$1,336	11	-47.6%	Shares	Defined	2023-08-11
2023-03-31	$3,225	21	-79.0%	Shares	Defined	2023-05-05
2021-09-30	$38,486	100	-50.0%	Shares	Defined	2021-11-04
2021-03-31	$26,190	200	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.